immunology

Biotech

Ikena, after tough year of layoffs, merges with Inmagene

After a year that saw Ikena trim its workforce and pipeline, the oncology biotech thinks it’s found a path forward via a merger into Inmagene.

James Waldron Dec 23, 2024 10:00am

Belharra beach in France

40% layoffs break Belharra's tidal wave

Dec 9, 2024 4:52pm

pivot change turnaround direction walk away

Kymera pivots to immunology, seeks partners for cancer assets

Nov 1, 2024 11:46am

Teva Pharmaceuticals

Teva brings biotech ethos to drug development, exec says

Oct 15, 2024 4:33pm

horse horse riding lasso man on horse in shadows

I&I biotech Triveni raises $115M for preclinical antibodies

Oct 2, 2024 7:00am

christmas cash gift money present holiday

UCLA scoops $120M gift for immunology and immunotherapy site

Aug 28, 2024 9:25am